Bon Natural Life Ltd
BON · Medicinal Chemicals & Botanical Products · EDGAR filings ↗
Grade
D50China botanical/nutritional ingredients maker that slipped to a loss year on falling revenue but holds a clean balance sheet.
Strengths
- Positive FCF ($134K) and very low leverage (D/E 0.01); current ratio 1.74, quick ratio 1.6 (79th pct)
- ROA -2.3% sits 76th pct relative to a weak sector
Risks
- Revenue -21.7% (12th pct) and swing to net loss (net margin -10.7%, net income down ~600%)
- Gross margin 20.8% (12th pct) and negative interest coverage
- All operations in China with PRC regulatory and capital-control exposure
Notable findings
- No interest coverageInterest coverage -4.43 (cannot cover interest)
- Net lossNet loss (net margin -10.7%)
- Revenue declineRevenue -21.7% YoY
Key metrics
Gross margin
20.8%
Operating margin
-8.7%
Net margin
-10.7%
Return on equity
-3.5%
Return on assets
-2.3%
ROIC
-2.2%
Revenue growth (QoQ)
-21.7%
Net-income growth
-601.0%
Debt / equity
0.0×
Interest coverage
-4.4×
Current ratio
1.7×
Free cash flow
$134K
EBITDA
-$536K
Tangible book value
$51M
Stock comp / revenue
7.5%
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 20-F | 2026-01-23 | 2025-09-30 | 0001493152-26-003270 ↗ |
| 20-F | 2025-01-28 | 2024-09-30 | 0001493152-25-003851 ↗ |
| 20-F | 2024-02-09 | 2023-09-30 | 0001493152-24-005772 ↗ |
| 20-F | 2023-02-10 | 2022-09-30 | 0001493152-23-004197 ↗ |
| 20-F | 2022-01-31 | 2021-09-30 | 0001493152-22-002688 ↗ |